迪特尔类类化合物的神经药理学潜力
Arash Salehi1, Mustafa Ghanadian1,2, Behzad Zolfaghari1
1Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Pharmaceuticals (Basel, Switzerland)
|May 27, 2023
概括
来自Aconitum和Delphinium物种的迪特尔类类化合物表现出多样化的中枢神经系统 (CNS) 活动,包括抗和止痛作用. 然而,神经毒性限制了它们的治疗潜力.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 迪特类类化合物 (DAs) 是复杂的自然产物,主要来自Ranunculaceae家族植物 (Aconitum,Delphinium).
- 这些化合物因其复杂的结构和显著的生物活动而被广泛研究,特别是影响中枢神经系统 (CNS).
研究的目的:
- 提供关于二类类化合物 (DAs) 的叙述性综述.
- 总结它们的结构分类,化学特征和各种生物活动,重点关注中枢神经系统的影响.
- 讨论开发DA作为治疗剂的挑战和局限性.
主要方法:
- 关于二类类化合物的文献综述.
- 化学结构的分析和DA的分类.
- 报告的生物活性,特别是中枢神经系统的影响和作用机制的摘要.
- 讨论临床前发现和神经毒性.
主要成果:
- 根据结构特征,DA被分为46种类型,并具有特征性的异环系统.
- 临床前研究表明,DA通过Na+通道产生抗作用,通过各种机制产生镇痛作用.
- 甲基利卡康尼丁对α7尼古丁乙胆受体 (nAChR) 具有很高的亲和力,影响神经传递.
结论:
- DAs表现出广泛的中枢神经系统活动,包括抗,止痛,神经保护,抗抑郁和抗焦虑作用.
- 尽管它们具有治疗潜力,但与DA相关的显著神经毒性阻碍了新药的开发.
- 需要进一步的研究,以了解和减轻DA的神经毒性作用,以获得潜在的治疗应用.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Opioid Receptors: Overview
1.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K


